Regional Insights: North America Leading the Blood Grouping Reagents Market
The Blood Grouping Reagents Market is dominated by North America due to well-established healthcare infrastructure, high awareness of blood safety, and advanced research facilities. The U.S. remains the largest contributor, with hospitals and blood banks investing in state-of-the-art reagents and automated typing systems.
Europe is also significant, driven by stringent regulatory standards and adoption of modern laboratory practices. Meanwhile, Asia-Pacific presents high growth potential due to increasing healthcare access and government initiatives in blood safety.
Market Outlook: The global market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, at a 7.1% CAGR.
1 View